Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma

NCT01753713 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Adult Giant Cell Glioblastoma
Adult Glioblastoma
Adult Gliosarcoma
Recurrent Adult Brain Tumor

Interventions

DRUG: dovitinib
OTHER: laboratory biomarker analysis

Sponsor

Manmeet Ahluwalia, MD

Collaborators

[object Object]
[object Object]